“Prospective Study to Ascertain the Advantages of Adding Neprilysin Inhibitor to Standard Care Among Patients With Congestive Cardiac Failure”. 2022. Innovative Journal of Medical and Health Sciences 12 (05): 1903-9. http://www.innovativejournal.in/index.php/ijmhs/article/view/3440.